These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 6141495

  • 1. Met-enkephalin-like and dynorphin-like immunoreactivities of the basal ganglia of the cat.
    Chesselet MF, Graybiel AM.
    Life Sci; 1983; 33 Suppl 1():37-40. PubMed ID: 6141495
    [Abstract] [Full Text] [Related]

  • 2. The comparison between enkephalin-like and dynorphin-like immunoreactivity in both monkey and human globus pallidus and substantia nigra.
    Haber SN, Watson SJ.
    Life Sci; 1983; 33 Suppl 1():33-6. PubMed ID: 6141493
    [Abstract] [Full Text] [Related]

  • 3. Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra.
    Quirion R, Gaudreau P, Martel JC, St-Pierre S, Zamir N.
    Brain Res; 1985 Apr 08; 331(2):358-62. PubMed ID: 2859094
    [Abstract] [Full Text] [Related]

  • 4. Primate model of Parkinson's disease: alterations in multiple opioid systems in the basal ganglia.
    Zamir N, Skofitsch G, Bannon MJ, Helke CJ, Kopin IJ, Jacobowitz DM.
    Brain Res; 1984 Nov 26; 322(2):356-60. PubMed ID: 6150750
    [Abstract] [Full Text] [Related]

  • 5. Opioid peptides in Huntington's disease: alterations in prodynorphin and proenkephalin system.
    Seizinger BR, Liebisch DC, Kish SJ, Arendt RM, Hornykiewicz O, Herz A.
    Brain Res; 1986 Jul 23; 378(2):405-8. PubMed ID: 2873872
    [Abstract] [Full Text] [Related]

  • 6. Dynorphin- and enkephalin-like immunoreactivity is altered in limbic-basal ganglia regions of rat brain after repeated electroconvulsive shock.
    Kanamatsu T, McGinty JF, Mitchell CL, Hong JS.
    J Neurosci; 1986 Mar 23; 6(3):644-9. PubMed ID: 2870139
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical localization of dynorphin (1-8) in hypothalamic magnocellular neurons: evidence for absence of proenkephalin.
    Weber E, Roth KA, Evans CJ, Chang JK, Barchas JD.
    Life Sci; 1986 Mar 23; 31(16-17):1761-4. PubMed ID: 6130434
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical evidence for different opioid systems in the rat superior cervical ganglion as revealed by imipramine treatment and receptor blockade.
    Folan JC, Heym C.
    J Chem Neuroanat; 1989 Mar 23; 2(2):107-18. PubMed ID: 2574980
    [Abstract] [Full Text] [Related]

  • 9. Evidence for enkephalin- and endorphin-immunoreactive cells in the anterior pituitary of the axolotl Ambystoma mexicanum.
    Leon-Olea M, Sanchez-Alvarez M, Piña AL, Bayon A.
    J Comp Neurol; 1991 Mar 15; 305(3):412-20. PubMed ID: 1674748
    [Abstract] [Full Text] [Related]

  • 10. Peptides derived from prodynorphin are decreased in basal ganglia of Huntington's disease brains.
    Dawbarn D, Zamir N, Waters CM, Hunt SP, Emson PC, Brownstein MJ.
    Brain Res; 1986 Apr 30; 372(1):155-8. PubMed ID: 2871898
    [Abstract] [Full Text] [Related]

  • 11. Characterization and localization of immunoreactive dynorphin, alpha-neo-endorphin, Met-enkephalin and substance P in human spinal cord.
    Przewłocki R, Gramsch C, Pasi A, Herz A.
    Brain Res; 1983 Nov 28; 280(1):95-103. PubMed ID: 6197139
    [Abstract] [Full Text] [Related]

  • 12. Differential distribution in rat basal ganglia of Met-enkephalin- and Met-enkephalin Arg6 Phe7-like peptides revealed by immunohistochemistry.
    Williams RG, Dockray GJ.
    Brain Res; 1982 May 20; 240(1):167-70. PubMed ID: 7046877
    [Abstract] [Full Text] [Related]

  • 13. Dopamine and methionine-enkephalin in human brain.
    Ploska A, Taquet H, Javoy-Agid F, Gaspar P, Cesselin F, Berger B, Hamon M, Legrand JC, Agid Y.
    Neurosci Lett; 1982 Nov 30; 33(2):191-6. PubMed ID: 7155460
    [No Abstract] [Full Text] [Related]

  • 14. RIA/chromatographic evidence for novel opioid peptide(s) in Squilla mantis ganglia.
    Palmisano A, Marino G, Di Marzo V, Morris HR, Howlett TA, Tomlin S.
    Neuropeptides; 1986 Apr 30; 7(3):281-9. PubMed ID: 2872612
    [Abstract] [Full Text] [Related]

  • 15. Extensive co-occurrence of substance P and dynorphin in striatal projection neurons: an evolutionarily conserved feature of basal ganglia organization.
    Anderson KD, Reiner A.
    J Comp Neurol; 1990 May 15; 295(3):339-69. PubMed ID: 1693632
    [Abstract] [Full Text] [Related]

  • 16. Immunocytochemical studies of substance P and Met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's and Alzheimer's diseases.
    Grafe MR, Forno LS, Eng LF.
    J Neuropathol Exp Neurol; 1985 Jan 15; 44(1):47-59. PubMed ID: 2578185
    [Abstract] [Full Text] [Related]

  • 17. Chronic haloperidol and clozapine differentially affect dynorphin peptides and substance P in basal ganglia of the rat.
    Nylander I, Terenius L.
    Brain Res; 1986 Aug 13; 380(1):34-41. PubMed ID: 2428423
    [Abstract] [Full Text] [Related]

  • 18. Changes in dynorphin, enkephalin and cholecystokinin content of hippocampus and substantia nigra after amygdala kindling.
    Iadarola MJ, Shin C, McNamara JO, Yang HY.
    Brain Res; 1986 Feb 12; 365(1):185-91. PubMed ID: 2868784
    [Abstract] [Full Text] [Related]

  • 19. Localization and quantitation of dynorphin B in the rat hippocampus.
    Hoffman DW, Zamir N.
    Brain Res; 1984 Dec 24; 324(2):354-7. PubMed ID: 6152189
    [Abstract] [Full Text] [Related]

  • 20. An ion exchange chromatography and radioimmunoassay procedure for measuring opioid peptides and substance P.
    Bergström L, Christensson I, Folkesson R, Stenström B, Terenius L.
    Life Sci; 1983 Oct 17; 33(16):1613-9. PubMed ID: 6195501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.